Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Medical Devices Market

PRODUCT TITLE PUBLISHED
North America Spine Bone Stimulators Market North America Spine Bone Stimulators Market
The report “The North American Spine Bone Stimulator devices market forecast 2012-2014” analyzes the market by technology as Electrical Stimulators devices into 2 segments such as Non-invasive and Invasive. Further, Non-Invasive Stimulators are divide by technology into 3, as Pulsed Electromagnetic Field Devices and Capacitive Coupling & Combined (electro) Magnetic Field Devices.
Upcoming
Europe Spine Bone Stimulators Market Europe Spine Bone Stimulators Market
The report “The European Spine Bone Stimulator devices market forecast 2012-2014” analyzes the market by technology as Electrical Stimulators devices into 2 segments such as Non-invasive and Invasive. Further, Non-Invasive Stimulators are divide by technology into 3, as Pulsed Electromagnetic Field Devices and Capacitive Coupling & Combined (electro) Magnetic Field Devices.
Upcoming
Asia Non-Fusion Technologies Market Asia Non-Fusion Technologies Market
The report “The Asian Non-Fusion Technologies market forecast 2012-2014” analyzes the market of devices by 2 segments such as Dynamic Stabilization and Artificial Disc Replacement. All these segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing maximum growth because of increase in patient pool and procedure numbers of osteoarthritis and rheumatoid arthritis.Some of the key players in The Asian Non-Fusion Technologies market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Europe Non-Fusion Technologies Market Europe Non-Fusion Technologies Market
The report “The European Non-Fusion Technologies market forecast 2012-2014” analyzes the market of devices by 2 segments such as Dynamic Stabilization and Artificial Disc Replacement. All these segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques. Both the markets have been witnessing maximum growth because of increase in patient pool and procedure numbers of osteoarthritis and rheumatoid arthritis.   What makes our report unique? You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or...
Upcoming
North America Non-Fusion Technologies Market North America Non-Fusion Technologies Market
The North American Non-Fusion Technologies market has seen challenging and dynamic market conditions. The North American Spinal Fusion & Fixation market, mainly driven by aging population and the increasing prevalence of rheumatoid and osteoarthritis.Some of the key players in The North American Non-Fusion Technologies market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Asia Vertebral Compression Fracture Treatment Market Asia Vertebral Compression Fracture Treatment Market
The report “The Asian Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices. Some of the key players in The Asian Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
Europe Vertebral Compression Fracture Treatment Market Europe Vertebral Compression Fracture Treatment Market
The report “The European Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The European Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
North America Vertebral Compression Fracture Treatment Market North America Vertebral Compression Fracture Treatment Market
The report “The North American Vertebral Compression Fracture treatment market forecast 2012-2014” analyzes the market by technology devices into 2 segments such as Vertebroplasty and Balloon Kyphoplasty Devices.Some of the key players in The North American Vertebral Compression Fracture treatment market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Upcoming
North American Pulmonary drug delivery devices Market North American Pulmonary drug delivery devices Market
The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
European Pulmonary drug delivery devices Market European Pulmonary drug delivery devices Market
The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
Asian Pulmonary Drug Delivery devices Market Asian Pulmonary Drug Delivery devices Market
The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
North American Active Transdermal Drug Delivery Devices Market North American Active Transdermal Drug Delivery Devices Market
The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Active Transdermal Drug Delivery Devices Market European Active Transdermal Drug Delivery Devices Market
The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Active Transdermal Drug Delivery Devices Market Asian Active Transdermal Drug Delivery Devices Market
The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Passive Transdermal Drug Delivery Market North American Passive Transdermal Drug Delivery Market
The North American Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $6.85 billion in 2013 and expected to be $11.33 billion by 2018, growing at a CAGR of 10.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Passive Transdermal Drug Delivery Market European Passive Transdermal Drug Delivery Market
The European Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $3.27 billion in 2013 and expected to be $5.19 billion by 2018, growing at a CAGR of 9.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Passive Transdermal Drug Delivery Market Asian Passive Transdermal Drug Delivery Market
The Asian Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $1.40 billion in 2013 and expected to be $2.82 billion by 2018, growing at a CAGR of 15.0%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Sutures Market Asian Sutures Market
The Asian Sutures Market was valued at $145 million in 2013 and estimated to be $169 million by 2018, at a CAGR of 3.2%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare.
Upcoming
European Sutures Market European Sutures Market
The European Sutures Market was valued at $233 million in 2013 and estimated to be $246 million by 2018, at a CAGR of 1.30%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare, Smith & Nephew, 3M healthcare and others.
Upcoming
North American Sutures Market North American Sutures Market
The North American Sutures Market was valued at $705 million in 2013 and estimated to be $763 million by 2018, at a CAGR of 1.80%. Sutures in terms of types are divided into absorbable and non-absorbable sutures and on the basis of materials are divided into natural and synthetic sutures. The key players of the market covered in this report are 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare, Smith & Nephew and others.
Upcoming
1287 reports | Show
Connect With Us
US/CAN : +1-888-502-0539
infertility Treatment